The smart scale market has woken up after years of stagnation, according to a WIRED product roundup published in October 2026. The article attributes the surge almost certainly to the GLP-1 craze, with millions of consumers using weekly weigh-ins to judge whether their medication routine is working. This demand has pulled in new devices that go far beyond simple weight readings, including heart-rate monitors, muscle-composition breakdowns, and even ECG-based heart-health checks.
The biggest shift in the past year, WIRED notes, is a flood of full-body scanners. These bathroom scales add handlebar-based sensors, scanning through both feet and hands to produce more holistic—and often higher—body-fat estimates. The trade-off is price: top-tier models like the Withings BodyScan 2 now retail at $600. WIRED's reviewer says the data from these scanners can swing body-fat readings by up to 6 percent compared with floor scales, but still advises that consistent weigh-ins and tracking over time matter more than absolute accuracy.
For most users, the article recommends a standard smart scale, which remains considerably cheaper and likely good enough except for serious athletes. The overall pick is the Withings Body Comp, though the review flags a quirk: its heart-rate measurement regularly runs about 10 beats per minute too fast. That caveat aside, the category's expansion—and its rising price ceiling—signals a maturing market now tied closely to the broader weight-loss drug boom.